Journal article
Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.
Abstract
OBJECTIVE: To compare live birth rates in women with recurrent pregnancy loss (RPL) and either autoantibodies or a coagulation abnormality, treated with low molecular weight heparin plus aspirin (LMWH/ASA) or ASA alone, and to place our results in context with other randomized clinical trials (RCT) with similar cohorts.
METHODS: The HepASA Trial was an RCT including patients with a history of RPL and at least 1 of the following: …
Authors
Laskin CA; Spitzer KA; Clark CA; Crowther MR; Ginsberg JS; Hawker GA; Kingdom JC; Barrett J; Gent M
Journal
The Journal of Rheumatology, Vol. 36, No. 2, pp. 279–287
Publication Date
February 2009
DOI
10.3899/jrheum.080763)
ISSN
0315-162X
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Abortion, HabitualAdultAntibodies, AntinuclearAnticoagulantsAntiphospholipid SyndromeAspirinAutoimmune DiseasesBlood Coagulation DisordersBone DensityCohort StudiesFemaleHeparin, Low-Molecular-WeightHumansPlatelet Aggregation InhibitorsPregnancyPregnancy Complications, HematologicThrombophiliaTreatment Outcome